Articles Tagged With: Depression
-
Report: Anxiety, Depression Up Significantly Among U.S. Children 2016-2020
Even before the onset of the COVID-19 pandemic, mental health conditions among Americans age 3 to 17 years were trending negatively.
-
Psilocybin Produces Long-Term Antidepressive Benefits
Some patients sustained positive effects up to one year after treatment.
-
Post-COVID-19 Behavioral Health for Patients and Providers
Questions about mental and behavioral health have been at the forefront of many minds, especially as the COVID-19 pandemic continues. Of course, the problem did not start with COVID-19. -
More U.S. Trauma Centers Offering Screening, Intervention Programs
Integrated mental health approach includes addressing PTSD, alcohol, opioids, firearms, and suicidal ideation.
-
Unique Ethical Issues with Research on Difficult-to-Treat Depression
Researchers should focus on these three areas: How to define this group of patients, which is heterogenous; how to acquire and interpret clinically meaningful outcome metrics; and how to design clinical trials to promote generalizability.
-
From Homelessness to Self-Sufficiency, Case Management-Style Program Works
Case managers increasingly recognize the importance of addressing social determinants of health among patients across the care continuum, but evidence-based interventions are scarce. One new program seeks to change this with tactics to address one of the most prevalent social determinants of health: Poverty. A novel care transition and community case management program provides an evidence-based standard of care to treat poverty as an environmentally based and treatable condition.
-
Meat Consumption Associated with Less Anxiety and Depression
A meta-analysis of 20 studies showed meat consumption resulted in better mental health, with less anxiety and depression vs. meat abstinence.
-
Zuranolone Trial Shows Early Promise as an Oral Neuroactive Steroid for the Treatment of Postpartum Depression
Zuranolone was approved by the Food and Drug Administration for the treatment of postpartum depression (PPD) in March 2019. One potential factor identified in PPD etiology is the dramatic perinatal changes in circulating levels of allopregnanolone, a neuroactive steroid with gamma-aminobutyric acid type A (GABAA) receptor positive allosteric modulator properties. In brain regions associated with emotion and self-perception, neural network connectivity supported by GABAergic signaling is positively correlated with plasma allopregnanolone concentrations in individuals with PPD vs. healthy postpartum female individuals.
-
Exodus: Emotional Suffering Driving Nurses from the Field
According to a survey by the American Nurses Foundation, nurses feel “betrayed,” “guilty,” and “like a failure.” Nurses reported feeling exhausted, overwhelmed, irritable, and anxious. One percent of respondents expressed suicidal ideation. -
Ketamine Use in the Prevention of Postpartum Depression Is Premature
A double-blinded, randomized clinical trial of 134 low-risk pregnant women in Iran undergoing scheduled cesarean deliveries was conducted to address if a single dose of ketamine during anesthesia induction has a role in the prevention of postpartum depression. The authors reported that depression scores using the Edinburgh Postnatal Depression Scale at two and four weeks after the cesarean delivery were significantly lower in the ketamine group vs. the control group.